Ground-glass opacity

Last updated

High-resolution CT image showing ground-glass opacities in the periphery of both lungs in a patient with COVID-19 (red arrows). The adjacent normal lung tissue with lower attenuation appears as darker areas. COVID-19-Longontsteking.jpg
High-resolution CT image showing ground-glass opacities in the periphery of both lungs in a patient with COVID-19 (red arrows). The adjacent normal lung tissue with lower attenuation appears as darker areas.

Ground-glass opacity (GGO) is a finding seen on chest x-ray (radiograph) or computed tomography (CT) imaging of the lungs. It is typically defined as an area of hazy opacification (x-ray) or increased attenuation (CT) due to air displacement by fluid, airway collapse, fibrosis, or a neoplastic process. [1] When a substance other than air fills an area of the lung it increases that area's density. On both x-ray and CT, this appears more grey or hazy as opposed to the normally dark-appearing lungs. Although it can sometimes be seen in normal lungs, common pathologic causes include infections, interstitial lung disease, and pulmonary edema. [2] [3]

Contents

Definition

In both CT and chest radiographs, normal lungs appear dark due to the relative lower density of air compared to the surrounding tissues. When air is replaced by another substance (e.g. fluid or fibrosis), the density of the area increases, causing the tissue to appear lighter or more grey. [4]

Ground-glass opacity is most often used to describe findings in high-resolution CT imaging of the thorax, although it is also used when describing chest radiographs. In CT, the term refers to one or multiple areas of increased attenuation (density) without concealment of the pulmonary vasculature. This appears more grey, as opposed to the normally dark-appearing (air-filled) lung on CT imaging. In chest radiographs, the term refers to one or multiple areas in which the normally darker-appearing (air-filled) lung appears more opaque, hazy, or cloudy. Ground-glass opacity is in contrast to consolidation, in which the pulmonary vascular markings are obscured. [3] [5] GGO can be used to describe both focal and diffuse areas of increased density. [5] Subtypes of GGOs include diffuse, nodular, centrilobular, mosaic, crazy paving, halo sign, and reversed halo sign. [6]

Causes

The differential diagnosis for ground-glass opacities is broad. General etiologies include infections, interstitial lung diseases, pulmonary edema, pulmonary hemorrhage, and neoplasm. A correlation of imaging with a patient's clinical features is useful in narrowing the diagnosis. [6] [7] GGOs can be seen in normal lungs. Upon expiration there is less air in the lungs, leading to a relative increase in density of the tissue, and thus increased attenuation on CT. Furthermore, when a patient lays supine for a CT scan, the posterior lungs are in a dependent position, causing partial collapse of the posterior alveoli. This leads to an increase in density of the tissue, resulting increased attenuation and a possible ground-glass appearance on CT. [3]

Infectious causes

In the setting of pneumonia, the presence of GGO (as opposed to consolidation) is a useful diagnostic clue. Most bacterial infections lead to lobar consolidation, while atypical pneumonias may cause GGOs. It is important to note that while many of the pulmonary infections listed below may lead to GGOs, this does not occur in every case. [2] [6] [7] [8] [9]

High-Resolution CT image in a patient with Pneumocystis pneumonia infection showing ground-glass opacities. CT of infiltrates of pneumocystis pneumonia.jpg
High-Resolution CT image in a patient with Pneumocystis pneumonia infection showing ground-glass opacities.

Bacterial

Viral

Fungal

Parasitic

Non-infectious causes

CT image showing patchy areas of ground-glass opacities representing pulmonary edema. Patron de ground glass parcheado.jpg
CT image showing patchy areas of ground-glass opacities representing pulmonary edema.

Exposures

Idiopathic interstitial pneumonia

Neoplastic processes

Additional causes

Patterns

There are seven general patterns of ground-glass opacities. [6] When combined with a patient's clinical signs and symptoms, the GGO pattern seen on imaging is useful in narrowing the differential diagnosis. It is important to note that while some disease processes present as only one pattern, many can present with a mixture of GGO patterns. [6]

Diffuse

The diffuse pattern typically refers to GGOs in multiple lobes of one or both lungs. Broadly, a diffuse pattern of GGO can be caused by displacement of air with fluid, inflammatory debris, or fibrosis. Cardiogenic pulmonary edema and ARDS are common causes of a fluid-filled lung. Diffuse alveolar hemorrhage is a rarer cause of diffuse GGO seen in some types of vasculitis, autoimmune conditions, and bleeding disorders. [6]

Inflammation and fibrosis can also cause diffuse GGOs. Pneumocystis pneumonia, an infection typically seen in immunocompromised (e.g. patients with AIDS) or immunosuppressed individuals, is a classic cause of diffuse GGOs. Many viral pneumonias and idiopathic interstitial pneumonias can also lead to a diffuse GGO pattern. Radiation pneumonitis, a side effect of pulmonary radiation therapy, can lead to pulmonary fibrosis and diffuse GGOs. [6]

Nodular

There are numerous potential causes of nodular GGOs which can be broadly separated into benign and malignant conditions. Benign conditions potentially leading to the formation of nodular GGOs include aspergillosis, acute eosinophilic pneumonia, focal interstitial fibrosis, granulomatosis with polyangiitis, IgA vasculitis, organizing pneumonia, pulmonary contusion, pulmonary cryptococcus, and thoracic endometriosis. Focal interstitial fibrosis presents a unique challenge when differentiating from malignant nodular GGOs on CT imaging. It is typically persistent over long-term imaging follow-up and shares a similar appearance to malignant nodular GGOs. [9]

Pre-malignant or malignant causes of nodular GGOs include adenocarcinoma, adenocarcinoma in situ, and atypical adenomatous hyperplasia (AAH). One large review study found that 80% of nodular GGOs which were present on repeated CT imaging represented either pre-malignant or malignant growths. Differentiating between pre-malignancy and malignancy on the basis of CT alone can pose a challenge to radiologists; however, there are several features that are indicative of pre-malignant nodules. AAH is a pre-malignant cause of nodular GGO and is more commonly associated with lower attenuation on CT and smaller nodule size (<10 mm) compared to adenocarcinoma. [10] In addition, AAH often lacks the solid features and spiculated appearance that are often associated with malignant growths. [9] In contrast, as adenocarcinoma becomes invasive it will more often cause retraction of adjacent pleura and may show an increase in vascular markings. Nodules >15 mm almost always represent an invasive adenocarcinoma. [9] [10]

Centrilobular

Centrilobular GGOs refer to opacities occurring within one or multiple secondary lobules of the lung, which consist of a respiratory bronchiole, small pulmonary artery, and the surrounding tissue. [3] A defining feature of these GGOs is the lack of involvement of the interlobular septum. Potential causes of centrilobular GGOs include pulmonary calcifications from metastatic disease, some types of idiopathic interstitial pneumonias, hypersensitivity pneumonitis, aspiration pneumonitis, cholesterol granulomas, and pulmonary capillary hemangiomastosis. [6]

Mosaic

A mosaic pattern of GGO refers to multiple irregular areas of both increased attenuation and decreased attenuation on CT. It is often the result of occlusion of small pulmonary arteries or obstruction of small airways leading to air trapping. [6] Sarcoidosis is an additional cause of a mosaic GGOs due to the formation of granulomas in interstitial areas. This may coexist with granulomatosis with polyangiitis, leading to diffuse areas of increased attenuation with ground-glass appearance. [6]

Crazy paving

The crazy paving pattern may occur when there is both interlobular and intralobular widening. This sometimes resembles a road paved with irregular bricks or tiles. It is typically diffuse, involving larger areas of one or multiple lobes. There are a variety of potential causes, including Pneumocystis pneumonia, late-stage adenocarcinoma, pulmonary edema, some types of idiopathic interstitial pneumonias, diffuse alveolar hemorrhage, sarcoidosis, and pulmonary alveolar proteinosis. [6] COVID-19 has also been shown to occasionally cause GGOs with a crazy paving pattern. [11]

Halo sign

A halo sign refers to a GGO that fills the area around a consolidation or nodule. This is a most commonly seen in various types of pulmonary infections, including CMV pneumonia, tuberculosis, nocardia infection, some fungal pneumonias, and septic emboli. Schistosomiasis, a parasitic infection, also commonly presents with the halo sign. Important non-infectious causes include granulomatosis with polyangiitis, metastatic disease with pulmonary hemorrhage, and some types of idiopathic interstitial pneumonias. [6]

Reversed halo sign

A reversed halo sign is a central ground-glass opacity surrounded by denser consolidation. According to published criteria, the consolidation should form more than three-fourths of a circle and be at least 2 mm thick. [12] It is often suggestive of organizing pneumonia, [13] but is only seen in about 20% of individuals with this condition. [12] It can also be present in lung infarction where the halo consists of hemorrhage, [14] as well as in infectious diseases such as paracoccidioidomycosis, tuberculosis, and aspergillosis, as well as in granulomatosis with polyangiitis, lymphomatoid granulomatosis, and sarcoidosis. [15]

COVID-19

CT image in patient with COVID-19 showing bilateral ground-glass opacities at the periphery of both lungs. COVID-19 Pneumonie - 74m CTcor - 002.jpg
CT image in patient with COVID-19 showing bilateral ground-glass opacities at the periphery of both lungs.

Ground-glass opacity is among the most common imaging findings in patients with confirmed COVID-19. [16] [17] One systematic review found that among patients with COVID-19 and abnormal lung findings on CT, greater than 80% had GGOs, with greater than 50% having mixed GGOs and consolidation. [16] GGOs with mixed consolidation has most often been found in elderly populations. [18] Several studies have described a pattern among initial, intermediate, and hospital discharge imaging findings in the disease course of COVID-19. Most commonly, initial CT imaging reveals bilateral GGOs at the periphery of the lungs. During initial stages, this is most often found in the lower lobes, although involvement of the upper lobes and right middle lobe has also been reported early in the disease course. [16] [18] This is in contrast to the two similar coronaviruses, SARS and MERS, which more commonly involve only one lung on initial imaging. [19] [20] As the COVID-19 infection progresses, GGOs typically become more diffuse and often progress to consolidation. [11] [18] This is sometimes accompanied by the development of a crazy paving pattern and interlobular septal thickening. [18] In many cases the most severe pulmonary CT abnormalities occurred within 2 weeks after symptoms began. [17] At this point, many individuals begin showing resolution of consolidation and GGOs as symptoms improve. However, some patients have worsening symptoms and imaging findings, with further increase in septal thickening, GGOs, and consolidation. These patients may develop lung "white-out" with progression to acute respiratory distress syndrome (ARDS) requiring treatment escalation. [17] [21]

Preliminary reports have shown many patients have residual GGOs at time of discharge from the hospital. Due to the novelty of COVID-19, large studies investigating the long-term pulmonary CT changes have yet to be completed. However, long-term pulmonary changes have been seen in patients after recovery from SARS and MERS, suggesting the possibility of similar long-term complications in patients who have recovered from acute COVID-19 infection. [22]

History

The first usage of "ground-glass opacity" by a major radiological society occurred in a 1984 publication of the American Journal of Roentgenology. It was published as part of a glossary of recommended nomenclature from the Fleischner Society, a group of thoracic imaging radiologists. [23] The original published definition read as: "Any extended, finely granular pattern of pulmonary opacity within which normal anatomic details are partly obscured; from a fancied resemblance to etched or abraded glass." [23] It was again included in an updated glossary by the Fleischner Society in 2008 with a more detailed definition. [24]

See also

Related Research Articles

<span class="mw-page-title-main">Interstitial lung disease</span> Group of diseases

Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD), is a group of respiratory diseases affecting the interstitium and space around the alveoli of the lungs. It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of tissue to repair damage, but in interstitial lung disease, the repair process is disrupted, and the tissue around the air sacs (alveoli) becomes scarred and thickened. This makes it more difficult for oxygen to pass into the bloodstream. The disease presents itself with the following symptoms: shortness of breath, nonproductive coughing, fatigue, and weight loss, which tend to develop slowly, over several months. The average rate of survival for someone with this disease is between three and five years. The term ILD is used to distinguish these diseases from obstructive airways diseases.

<span class="mw-page-title-main">Chest radiograph</span> Projection X-ray of the chest

A chest radiograph, called a chest X-ray (CXR), or chest film, is a projection radiograph of the chest used to diagnose conditions affecting the chest, its contents, and nearby structures. Chest radiographs are the most common film taken in medicine.

<span class="mw-page-title-main">Hypersensitivity pneumonitis</span> Medical condition

Hypersensitivity pneumonitis (HP) or extrinsic allergic alveolitis (EAA) is a syndrome caused by the repetitive inhalation of antigens from the environment in susceptible or sensitized people. Common antigens include molds, bacteria, bird droppings, bird feathers, agricultural dusts, bioaerosols and chemicals from paints or plastics. People affected by this type of lung inflammation (pneumonitis) are commonly exposed to the antigens by their occupations, hobbies, the environment and animals. The inhaled antigens produce a hypersensitivity immune reaction causing inflammation of the airspaces (alveoli) and small airways (bronchioles) within the lung. Hypersensitivity pneumonitis may eventually lead to interstitial lung disease.

<span class="mw-page-title-main">Pneumonitis</span> General inflammation of lung tissue

Pneumonitis describes general inflammation of lung tissue. Possible causative agents include radiation therapy of the chest, exposure to medications used during chemo-therapy, the inhalation of debris, aspiration, herbicides or fluorocarbons and some systemic diseases. If unresolved, continued inflammation can result in irreparable damage such as pulmonary fibrosis.

<span class="mw-page-title-main">Cryptogenic organizing pneumonia</span> Medical condition

Cryptogenic organizing pneumonia (COP), formerly known as bronchiolitis obliterans organizing pneumonia (BOOP), is an inflammation of the bronchioles (bronchiolitis) and surrounding tissue in the lungs. It is a form of idiopathic interstitial pneumonia.

<span class="mw-page-title-main">Lipid pneumonia</span> Lung inflammation caused by lipids in the bronchial tree

Lipoid pneumonia is a specific form of lung inflammation (pneumonia) that develops when lipids enter the bronchial tree. The disorder is sometimes called cholesterol pneumonia in cases where that lipid is a factor.

<span class="mw-page-title-main">Lymphangiomatosis</span> Medical condition

Lymphangiomatosis is a condition where a lymphangioma is not present in a single localised mass, but in a widespread or multifocal manner. It is a rare type of tumor which results from an abnormal development of the lymphatic system.

<i>Pneumocystis</i> pneumonia Medical condition

Pneumocystis pneumonia (PCP), also known as Pneumocystis jirovecii pneumonia (PJP), is a form of pneumonia that is caused by the yeast-like fungus Pneumocystis jirovecii.

<span class="mw-page-title-main">Usual interstitial pneumonia</span> Medical condition

Usual interstitial pneumonia (UIP) is a form of lung disease characterized by progressive scarring of both lungs. The scarring (fibrosis) involves the pulmonary interstitium. UIP is thus classified as a form of interstitial lung disease.

<span class="mw-page-title-main">High-resolution computed tomography</span> Diagnostic imaging test

High-resolution computed tomography (HRCT) is a type of computed tomography (CT) with specific techniques to enhance image resolution. It is used in the diagnosis of various health problems, though most commonly for lung disease, by assessing the lung parenchyma. On the other hand, HRCT of the temporal bone is used to diagnose various middle ear diseases such as otitis media, cholesteatoma, and evaluations after ear operations.

<span class="mw-page-title-main">Tree-in-bud sign</span> Medical condition

In radiology, the tree-in-bud sign is a finding on a CT scan that indicates some degree of airway obstruction. The tree-in-bud sign is a nonspecific imaging finding that implies impaction within bronchioles, the smallest airway passages in the lung. The differential for this finding includes malignant and inflammatory etiologies, either infectious or sterile. This includes fungal infections, mycobacterial infections such as tuberculosis or mycobacterium avium intracellulare, bronchopneumonia, chronic aspiration pneumonia, cystic fibrosis or cellular impaction from bronchovascular spread of malignancy, as can occur with breast cancer, leukemia or lymphoma. It also includes lung manifestations of autoimmune diseases such as Sjögren syndrome or rheumatoid arthritis.

Carcinosis, or carcinomatosis, is disseminated cancer, forms of metastasis, whether used generally or in specific patterns of spread.

<span class="mw-page-title-main">Lung nodule</span> Medical condition

A lung nodule or pulmonary nodule is a relatively small focal density in the lung. A solitary pulmonary nodule (SPN) or coin lesion, is a mass in the lung smaller than three centimeters in diameter. A pulmonary micronodule has a diameter of less than three millimetres. There may also be multiple nodules.

<span class="mw-page-title-main">Respiratory bronchiolitis</span> Medical condition

Respiratory bronchiolitis is a lung disease associated with tobacco smoking. In pathology, it is defined by the presence of "smoker's macrophages". When manifesting significant clinical symptoms it is referred to as respiratory bronchiolitis interstitial lung disease (RB-ILD).

<span class="mw-page-title-main">Fire breather's pneumonia</span> Medical condition

Fire breather's pneumonia is a distinct type of exogenous—that is, originating outside the body—lipoid pneumonia that results from inhalation or aspiration of hydrocarbons of different types, such as lamp oil. Accidental inhalation of hydrocarbon fuels can occur during fire breathing, fire eating, or other fire performance, and may lead to pneumonitis.

<span class="mw-page-title-main">Pulmonary alveolar microlithiasis</span> Medical condition

Pulmonary alveolar microlithiasis (PAM) is a rare, inherited disorder of lung phosphate balance that is associated with small stone formation in the airspaces of the lung. Mutations in the gene SLC34A2 result in loss of a key sodium, phosphate co-transporter, known to be expressed in distal alveolar type II cells, as well as in the mammary gland, and to a lesser extent in intestine, kidney, skin, prostate and testes. As the disease progresses, the lung fields become progressively more dense (white) on the chest xray, and low oxygen level, lung inflammation and fibrosis, elevated pressures in the lung blood vessels, and respiratory failure ensue, usually in middle age. The clinical course of PAM can be highly variable, with some patients remaining asymptomatic for decades, and others progressing more rapidly. There is no effective treatment, and the mechanisms of stone formation, inflammation and scarring are not known.

<span class="mw-page-title-main">Air bronchogram</span>

An air bronchogram is defined as a pattern of air-filled bronchi on a background of airless lung.

Vaping-associated pulmonary injury (VAPI), also known as vaping-associated lung injury (VALI) or e-cigarette, or vaping, product use associated lung injury (E/VALI), is an umbrella term, used to describe lung diseases associated with the use of vaping products that can be severe and life-threatening. Symptoms can initially mimic common pulmonary diagnoses, such as pneumonia, but sufferers typically do not respond to antibiotic therapy. Differential diagnoses have overlapping features with VAPI, including COVID-19. According to an article in the Radiological Society of North America news published in March 2022, EVALI cases continue to be diagnosed. “EVALI has by no means disappeared,” Dr. Kligerman said. “We continue to see numerous cases, even during the pandemic, many of which are initially misdiagnosed as COVID-19.”

<span class="mw-page-title-main">Crazy paving (medicine)</span> Medical sign on CT of the chest

Crazy paving refers to a pattern seen on computed tomography of the chest, involving lobular septal thickening with variable alveolar filling. The finding is seen in pulmonary alveolar proteinosis, and other diseases. Its name comes from its resemblance to irregular paving stones, called crazy pavings.

<span class="mw-page-title-main">Smoking-related interstitial fibrosis (SRIF)</span> Abnormal amount of collagen in the lung (fibrosis) caused by cigarette smoking

Smoking-related interstitial fibrosis (SRIF) is an abnormality in the lungs characterized by excessive collagen deposition within the walls of the air sacs. This abnormality can be seen with a microscope and diagnosed by pathologists. It is caused by cigarette smoking.

References

  1. ↑ Goodman LR (2015). Felson's principles of chest roentgenology (Fifth ed.). Philadelphia, PA: Elsevier. pp. Supplement 3, e36–e80. ISBN   978-0-323-77795-7. OCLC   1134689400.
  2. 1 2 Mettler Jr FA (2019). Essentials of radiology (Fourth ed.). Philadelphia, PA: Elsevier. pp. 299–331. ISBN   978-0-323-56787-9. OCLC   1053711279.
  3. 1 2 3 4 Sharma A, Abbott G (2019). Thoracic imaging (Third ed.). Philadelphia, PA: Elsevier. ISBN   978-0-323-59699-2. OCLC   1022265855.
  4. ↑ Herring W (2020). Learning radiology : recognizing the basics (4th ed.). Philadelphia: Elsevier. pp. 2–4. ISBN   978-0-323-56728-2. OCLC   1096282271.
  5. 1 2 Walker CM, Chung JH (2019). Müller's imaging of the chest (2nd ed.). Philadelphia, PA: Elsevier. pp. 109–137. ISBN   978-0-323-53179-5. OCLC   1051135278.
  6. 1 2 3 4 5 6 7 8 9 10 11 12 El-Sherief AH, Gilman MD, Healey TT, Tambouret RH, Shepard JA, Abbott GF, Wu CC (2014). "Clear vision through the haze: a practical approach to ground-glass opacity". Current Problems in Diagnostic Radiology. 43 (3): 140–58. doi:10.1067/j.cpradiol.2014.01.004. PMID   24791617.
  7. 1 2 Parekh M, Donuru A, Balasubramanya R, Kapur S (July 2020). "Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era". Radiology. 297 (3): E289–E302. doi:10.1148/radiol.2020202504. PMC   7350036 . PMID   32633678.
  8. ↑ Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC (1 September 2000). "Pulmonary drug toxicity: radiologic and pathologic manifestations". Radiographics. 20 (5): 1245–59. doi:10.1148/radiographics.20.5.g00se081245. PMID   10992015.
  9. 1 2 3 4 Park CM, Goo JM, Lee HJ, Lee CH, Chun EJ, Im JG (1 March 2007). "Nodular ground-glass opacity at thin-section CT: histologic correlation and evaluation of change at follow-up". Radiographics. 27 (2): 391–408. doi:10.1148/rg.272065061. PMID   17374860.
  10. 1 2 Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM, Moon JW (March 2014). "Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management". AJR. American Journal of Roentgenology. 202 (3): W224-33. doi:10.2214/AJR.13.11819. PMID   24555618.
  11. 1 2 Ye Z, Zhang Y, Wang Y, Huang Z, Song B (August 2020). "Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review". European Radiology. 30 (8): 4381–4389. doi:10.1007/s00330-020-06801-0. PMC   7088323 . PMID   32193638.
  12. 1 2 Foley R, et al. "Reversed halo sign (lungs)". Radiopaedia . Retrieved 2 January 2018.
  13. ↑ Elicker BM, Webb WR (2012). Fundamentals of High-Resolution Lung CT: Common Findings, Common Patterns, Common Diseases, and Differential Diagnosis. Lippincott Williams & Wilkins. ISBN   9781469824796.
  14. ↑ Wu G, Schmit B, Arteaga V, Palacio D (2017). "Medical image of the week: pulmonary infarction- the "reverse halo sign"". Southwest Journal of Pulmonary and Critical Care. 15 (4): 162–163. doi: 10.13175/swjpcc124-17 . ISSN   2160-6773.
  15. ↑ Karthikeyan D (2013). High Resolution Computed Tomography of the Lungs: A Practical Guide. JP Medical Ltd. p. 256. ISBN   9789350904084.
  16. 1 2 3 Bao C, Liu X, Zhang H, Li Y, Liu J (June 2020). "Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis". Journal of the American College of Radiology. 17 (6): 701–709. doi:10.1016/j.jacr.2020.03.006. PMC   7151282 . PMID   32283052.
  17. 1 2 3 Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (July 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi: 10.2214/AJR.20.23034 . PMID   32174129.
  18. 1 2 3 4 Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (July 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi: 10.2214/AJR.20.23034 . PMID   32174129.
  19. ↑ Ooi GC, Daqing M (November 2003). "SARS: radiological features". Respirology. 8 Suppl (s1): S15-9. doi:10.1046/j.1440-1843.2003.00519.x. PMC   7169195 . PMID   15018128.
  20. ↑ Das KM, Lee EY, Langer RD, Larsson SG (June 2016). "Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know?". AJR. American Journal of Roentgenology. 206 (6): 1193–201. doi: 10.2214/AJR.15.15363 . PMID   26998804.
  21. ↑ Carotti M, Salaffi F, Sarzi-Puttini P, Agostini A, Borgheresi A, Minorati D, et al. (July 2020). "Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists". La Radiologia Medica. 125 (7): 636–646. doi:10.1007/s11547-020-01237-4. PMC   7270744 . PMID   32500509.
  22. ↑ George PM, Barratt SL, Condliffe R, Desai SR, Devaraj A, Forrest I, et al. (November 2020). "Respiratory follow-up of patients with COVID-19 pneumonia". Thorax. 75 (11): 1009–1016. doi:10.1136/thoraxjnl-2020-215314. PMC   7447111 . PMID   32839287.
  23. 1 2 Tuddenham WJ (September 1984). "Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society". AJR. American Journal of Roentgenology. 143 (3): 509–17. doi:10.2214/ajr.143.3.509. PMID   6380245.
  24. ↑ Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (March 2008). "Fleischner Society: glossary of terms for thoracic imaging". Radiology. 246 (3): 697–722. doi:10.1148/radiol.2462070712. PMID   18195376.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.